AR002956A1 - USEFUL PROTEINS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS, PROCESS TO OBTAIN THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. - Google Patents

USEFUL PROTEINS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS, PROCESS TO OBTAIN THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Info

Publication number
AR002956A1
AR002956A1 ARP960101202A AR10120296A AR002956A1 AR 002956 A1 AR002956 A1 AR 002956A1 AR P960101202 A ARP960101202 A AR P960101202A AR 10120296 A AR10120296 A AR 10120296A AR 002956 A1 AR002956 A1 AR 002956A1
Authority
AR
Argentina
Prior art keywords
obesity
contain
treatment
pharmaceutical compositions
related disorders
Prior art date
Application number
ARP960101202A
Other languages
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR002956A1 publication Critical patent/AR002956A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describen proteínas anti-obesidad que regulan la formación de tejido adiposo, de forma tal que dichos agentes permiten al paciente superar laobesidad. Se trata de proteínas que responden a la secuencia (SEQ ID NO:8)Anti-obesity proteins are described that regulate the formation of adipose tissue, in such a way that said agents allow the patient to overcome obesity. These are proteins that respond to the sequence (SEQ ID NO: 8)

ARP960101202A 1995-01-31 1996-01-30 USEFUL PROTEINS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS, PROCESS TO OBTAIN THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. AR002956A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38104895A 1995-01-31 1995-01-31
US38363895A 1995-02-06 1995-02-06
US45095P 1995-06-22 1995-06-22
US216195P 1995-08-11 1995-08-11

Publications (1)

Publication Number Publication Date
AR002956A1 true AR002956A1 (en) 1998-05-27

Family

ID=27484996

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101202A AR002956A1 (en) 1995-01-31 1996-01-30 USEFUL PROTEINS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS, PROCESS TO OBTAIN THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Country Status (15)

Country Link
JP (1) JPH10513451A (en)
KR (1) KR19980701798A (en)
AR (1) AR002956A1 (en)
AU (1) AU703316B2 (en)
BR (1) BR9606999A (en)
CA (1) CA2211784A1 (en)
CO (1) CO4480035A1 (en)
CZ (1) CZ240497A3 (en)
FI (1) FI973162A (en)
NO (1) NO973515L (en)
NZ (1) NZ301589A (en)
PE (1) PE15197A1 (en)
PL (1) PL321702A1 (en)
TR (1) TR199600085A2 (en)
YU (1) YU5296A (en)

Also Published As

Publication number Publication date
AU4705296A (en) 1996-08-21
YU5296A (en) 1998-08-14
NZ301589A (en) 1999-02-25
NO973515D0 (en) 1997-07-30
PE15197A1 (en) 1997-05-22
CO4480035A1 (en) 1997-07-09
TR199600085A2 (en) 1996-08-21
CZ240497A3 (en) 1998-01-14
JPH10513451A (en) 1998-12-22
BR9606999A (en) 1997-10-28
NO973515L (en) 1997-09-29
KR19980701798A (en) 1998-06-25
FI973162A (en) 1997-09-30
FI973162A0 (en) 1997-07-30
AU703316B2 (en) 1999-03-25
PL321702A1 (en) 1997-12-22
CA2211784A1 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
HK1043543A1 (en) Modified factor VIII.
DK155143C (en) ANTIOESTROGENT MEDICINE FOR TREATMENT OF BONEY AND CANCEROUS CONDITIONS IN THE BREAST
ATE299710T1 (en) METHODS OF TREATING MUSCLE DISEASES AND MUSCLE DISORDERS
IL151371A0 (en) Modified porcine factor viii and pharmaceutical compositions containing the same
ES2113635T3 (en) APPLICATION OF RILUZOLE IN THE TREATMENT OF NEUROLOGIC INJURIES RELATED TO INJURIES.
ES2114616T5 (en) INSULATED ALIFATIC DICARBOXILIC ACIDS.
IL113941A (en) Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them
PT758241E (en) USE OF CERTAIN METHANBOSPHOSPHONIC ACID DERIVATIVES TO PREVENT THE DISPOSAL OF PROTESES AND PROTEIN MIGRATION
DE69410254T2 (en) TREATMENT OF MYCOBACTERIAL DISEASES THROUGH THE ADMINISTRATION OF BACRERIAL-KILLING, PLEASURE-INCREASING PROTEIN FRAGMENTS
ATE171873T1 (en) ANTIGLUCOCORTICOID STEROIDS FOR THE TREATMENT OF ANXIETY DISORDERS
AR002742A1 (en) ADIPOSE TYPE REGULATORY PROTEIN, PROCEDURE TO PRODUCE SUCH PROTEIN, PHARMACEUTICAL FORMULATIONS INCLUDING IT, ISOLATED DNA MOLECULES THAT CODES SUCH PROTEIN, VECTOR AND RECOMBINANT CELLS THAT INCLUDE SUCH DNA
HUT64565A (en) Method for producing compounds and preparatives inhibiting resorption of bones
TR200200278T2 (en) Calcilitic compositions
AR002956A1 (en) USEFUL PROTEINS FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS, PROCESS TO OBTAIN THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DE69929683D1 (en) ANTISENSE MODULATION OF LFA-3
ATE194076T1 (en) USE OF N,S-DIACETYLCYSTEINE ETHYL ESTER (DACEE) FOR PRODUCING A MEDICATION FOR THE TREATMENT OF VIRAL DISEASES
DE69521200D1 (en) FORMULATION OF ENERGY
MX9206732A (en) NEW TROMBINE INHIBITING PROTEINS FROM SANGUIJUELAS DE TIERRA.
EE9900464A (en) Use of cartilage matrix oligomeric protein in the treatment of rheumatoid arthritis
ES2062502T3 (en) A PURE FACTOR I PROTEIN AND A PROCEDURE FOR OBTAINING SUCH PROTEIN.
MX9800686A (en) Novel protein hmw human mp52
KR920700224A (en) New bioactive peptide and calcium metabolism modulator containing it as an active ingredient
ATE312611T1 (en) USE OF MIZOLASTINE IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF INFLAMMATION
PL322847A1 (en) Condensed b-carbolins
GEP19991605B (en) Inhibitor, Its Obtaining and Use